Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics

Lee, 2016, Bioengineered protein-based nanocage for drug delivery, Adv. Drug Deliv. Rev., 106, 157, 10.1016/j.addr.2016.03.002

Molino, 2014, Caged protein nanoparticles for drug delivery, Curr. Opin. Biotechnol., 28, 75, 10.1016/j.copbio.2013.12.007

Schoonen, 2014, Functionalization of protein-based nanocages for drug delivery applications, Nano, 6, 7124

MaHam, 2009, Protein-based nanomedicine platforms for drug delivery, Small, 5, 1706, 10.1002/smll.200801602

Pieters, 2016, Natural supramolecular protein assemblies, Chem. Soc. Rev., 45, 24, 10.1039/C5CS00157A

Estrada, 2015, Protein nanoparticles for therapeutic protein delivery, Biomater. Sci., 3, 787, 10.1039/C5BM00052A

Truffi, 2016, Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer, Pharmacol. Res., 107, 57, 10.1016/j.phrs.2016.03.002

Jutz, 2015, Ferritin: a versatile building block for bionanotechnology, Chem. Rev., 115, 1653, 10.1021/cr400011b

Stefanini, 1996, Thermal stability of horse spleen apoferritin and human recombinant H apoferritin, Arch. Biochem. Biophys., 325, 58, 10.1006/abbi.1996.0007

Ahn, 2005, Heterologous gene expression using self-assembled supra-molecules with high affinity for HSP70 chaperone, Nucleic Acids Res., 33, 3751, 10.1093/nar/gki692

Kim, 2011, pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly, Biomacromolecules, 12, 1629, 10.1021/bm200026v

Takahashi, 2003, Functional properties of threefold and fourfold channels in ferritin deduced from electrostatic calculations, Biophys. J., 84, 2256, 10.1016/S0006-3495(03)75031-0

Pan, 2009, 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images, J. Struct. Biol., 166, 22, 10.1016/j.jsb.2008.12.001

Lin, 2011, Hybrid ferritin nanoparticles as activatable probes for tumor imaging, Angew. Chem. Int. Ed., 50, 1569, 10.1002/anie.201006757

Kwon, 2016, Enhanced in vivo tumor detection by active tumor cell targeting using multiple tumor receptor-binding peptides presented on genetically engineered human ferritin nanoparticles, Small, 12, 4241, 10.1002/smll.201600917

Lee, 2012, A novel bioassay platform using ferritin-based nanoprobe hydrogel, Adv. Mater., 24, 4739, 10.1002/adma.201200728

Kim, 2016, Designing peptide bunches on nanocage for bispecific or superaffinity targeting, Biomacromolecules, 17, 1150, 10.1021/acs.biomac.5b01753

Luo, 2015, Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery, Biomater. Sci., 3, 1386, 10.1039/C5BM00067J

Kang, 2012, Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform, Biomaterials, 33, 5423, 10.1016/j.biomaterials.2012.03.055

Han, 2014, Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development, Nanomed. Nanotech. Biol. Med., 10, 561, 10.1016/j.nano.2013.11.003

Aime, 2002, Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging, Angew. Chem. Int. Ed., 41, 1017, 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P

Uchida, 2009, Intracellular distribution of macrophage targeting ferritin-iron oxide nanocomposite, Adv. Mater., 21, 458, 10.1002/adma.200801209

Lin, 2011, Chimeric ferritin nanocages for multiple function loading and multimodal imaging, Nano Lett., 11, 814, 10.1021/nl104141g

Crich, 2006, Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe, Cancer Res., 66, 9196, 10.1158/0008-5472.CAN-06-1728

Yan, 2008, Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy, Chem. Commun., 4579, 10.1039/b810949d

Liang, 2014, H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection, Proc. Nat. Acad. Sci. U. S. A., 111, 14900, 10.1073/pnas.1407808111

Zhen, 2013, RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors, ACS Nano, 7, 4830, 10.1021/nn305791q

Bellini, 2014, Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in cancer cells, J. Control. Release, 196, 184, 10.1016/j.jconrel.2014.10.002

Yang, 2007, Encapsulation of platinum anticancer drugs by apoferritin, Chem. Commun., 3453, 10.1039/b705326f

Jeon, 2013, Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity, ACS Nano, 7, 7462, 10.1021/nn403184u

Lee, 2015, A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and gamma-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment, Adv. Mater., 27, 6637, 10.1002/adma.201503093

Barreto, 2011, Nanomaterials: applications in cancer imaging and therapy, Adv. Mater., 23, H18, 10.1002/adma.201100140

Aggarwal, 2009, Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Adv. Drug Deliv. Rev., 61, 428, 10.1016/j.addr.2009.03.009

Fisher, 2007, Ferritin: a novel mechanism for delivery of iron to the brain and other organs, Am. J. Physiol. Cell Physiol., 293, C641, 10.1152/ajpcell.00599.2006

Chen, 2005, TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis, J. Exp. Med., 202, 955, 10.1084/jem.20042433

Worwood, 1982, The clearance of 131I-human plasma ferritin in man, Blood, 60, 827, 10.1182/blood.V60.4.827.827

Mack, 1985, Characterization of the binding of ferritin to the rat liver ferritin receptor, Biochim. Biophys. Acta, 843, 164, 10.1016/0304-4165(85)90135-7

Mirshafiee, 2016, Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake, Biomaterials, 75, 295, 10.1016/j.biomaterials.2015.10.019

Vannucci, 2012, Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles, Int. J. Nanomedicine, 7, 1489

Tsukamoto, 2013, Effect of PEGylation on controllably spaced adsorption of ferritin molecules, Langmuir, 29, 12737, 10.1021/la4029595

Falvo, 2016, Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements, Biomacromolecules, 17, 514, 10.1021/acs.biomac.5b01446

Fracasso, 2016, Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness, J. Control. Release, 239, 10, 10.1016/j.jconrel.2016.08.010

Schellenberger, 2009, A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner, Nat. Biotechnol., 27, 1186, 10.1038/nbt.1588

Marti-Renom, 2000, Comparative protein structure modeling of genes and genomes, Annu. Rev. Biophys. Biomol. Struct., 29, 291, 10.1146/annurev.biophys.29.1.291

Maupetit, 2009, PEP-FOLD: an online resource for de novo peptide structure prediction, Nucleic Acids Res., 37, W498, 10.1093/nar/gkp323

Lee, 2015, Engineered Proteinticles for targeted delivery of siRNA to cancer cells, Adv. Funct. Mat., 25, 1279, 10.1002/adfm.201403680

Haeckel, 2014, XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation, J. Nucl. Med., 55, 508, 10.2967/jnumed.113.128108

Cleland, 2012, A novel long-acting human growth hormone fusion protein (vrs-317): enhanced in vivo potency and half-life, J. Pharm. Sci., 101, 2744, 10.1002/jps.23229

Ding, 2014, Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility, Bioconjug. Chem., 25, 1351, 10.1021/bc500215m

Gaberc-Porekar, 2008, Obstacles and pitfalls in the PEGylation of therapeutic proteins, Curr. Opin. Drug Discov. Dev., 11, 242

Gross, 2000, The structure of the chromophore within DsRed, a red fluorescent protein from coral, Proc. Nat. Acad. Sci. U. S. A., 97, 11990, 10.1073/pnas.97.22.11990

Wang, 2010, Nanoparticles for tumor targeted therapies and their pharmacokinetics, Curr. Drug Metab., 11, 129, 10.2174/138920010791110827

Smilgies, 2015, Molecular weight–gyration radius relation of globular proteins: a comparison of light scattering, small-angle X-ray scattering and structure-based data, J. Appl. Crystallogr., 48, 1604, 10.1107/S1600576715015551

Storni, 2004, Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects, J. Immunol., 172, 1777, 10.4049/jimmunol.172.3.1777

Goldinger, 2012, Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients, Eur. J. Immunol., 42, 3049, 10.1002/eji.201142361